Core Problem Statement

Corneal opacity is a major cause of blindness. Globally, millions wait for clear, viable donor corneas, but less than 5% receive life-changing transplants due to a severe shortage of donors.

Solution Overview

A regenerative medicine platform engineering lab-manufactured bio-engineered corneas for vision restoration without donor dependence. The platform also develops functional human tissues for drug testing and disease modelling across liver, lung, and skin, alongside a full-stack AI-driven cGMP-compliant platform for stem cell-derived exosomes.

Strategic Engagement Opportunities

Pandorum Technologies' bio-engineered tissue platform offers pharma companies a partner for joint clinical development and licensing. The technology aligns with national healthcare self-reliance goals and blindness control programme objectives.